Rockefeller Capital Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Rockefeller Capital Management's RXST Position: Q1 2026 in Review
Rockefeller Capital Management reduced its RxSight (RXST) stake by 94% in Q1 2026, selling an estimated $186K and leaving 1,473 shares worth $9.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4029.
Rockefeller Capital Management first reported a position in RXST in Q3 2025 and has held it in 3 quarters since. The position peaked at $248K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Rockefeller Capital Management held 1,473 shares of RxSight worth $9.07K as of Q1 2026.
- Rockefeller Capital Management sold 22,375 RxSight shares in Q1 2026, an estimated $186K.
- RxSight made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4029 holding.
- Rockefeller Capital Management first reported a position in RxSight in Q3 2025 and has held it in 3 quarters since.
- Rockefeller Capital Management's RxSight position peaked at $248K in Q4 2025.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.